| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | recombination hotspot binding | 2.33e-06 | 2 | 31 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.80e-04 | 13 | 31 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.36e-04 | 20 | 31 | 2 | GO:0042800 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 8.84e-06 | 85 | 32 | 4 | GO:0032436 | |
| GeneOntologyBiologicalProcess | positive regulation of reciprocal meiotic recombination | 1.40e-05 | 4 | 32 | 2 | GO:0010845 | |
| GeneOntologyBiologicalProcess | regulation of reciprocal meiotic recombination | 1.40e-05 | 4 | 32 | 2 | GO:0010520 | |
| GeneOntologyBiologicalProcess | positive regulation of ubiquitin-dependent protein catabolic process | 2.82e-05 | 114 | 32 | 4 | GO:2000060 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal protein catabolic process | 3.81e-05 | 123 | 32 | 4 | GO:1901800 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.13e-05 | 139 | 32 | 4 | GO:0032434 | |
| GeneOntologyBiologicalProcess | positive regulation of proteolysis involved in protein catabolic process | 7.83e-05 | 148 | 32 | 4 | GO:1903052 | |
| GeneOntologyBiologicalProcess | regulation of ubiquitin-dependent protein catabolic process | 1.85e-04 | 185 | 32 | 4 | GO:2000058 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 2.12e-04 | 75 | 32 | 3 | GO:0032922 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 2.12e-04 | 75 | 32 | 3 | GO:0051785 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 2.30e-04 | 77 | 32 | 3 | GO:0035567 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal protein catabolic process | 3.17e-04 | 213 | 32 | 4 | GO:0061136 | |
| GeneOntologyBiologicalProcess | positive regulation of non-canonical Wnt signaling pathway | 3.51e-04 | 18 | 32 | 2 | GO:2000052 | |
| GeneOntologyBiologicalProcess | negative regulation of NLRP3 inflammasome complex assembly | 3.92e-04 | 19 | 32 | 2 | GO:1900226 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 4.10e-04 | 228 | 32 | 4 | GO:0045732 | |
| GeneOntologyBiologicalProcess | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.57e-04 | 424 | 32 | 5 | GO:0043161 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammasome-mediated signaling pathway | 4.81e-04 | 21 | 32 | 2 | GO:0141086 | |
| GeneOntologyBiologicalProcess | regulation of proteolysis involved in protein catabolic process | 6.25e-04 | 255 | 32 | 4 | GO:1903050 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 7.40e-04 | 26 | 32 | 2 | GO:0045836 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 9.46e-04 | 285 | 32 | 4 | GO:0060828 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 1.11e-03 | 516 | 32 | 5 | GO:0016055 | |
| GeneOntologyBiologicalProcess | regulation of non-canonical Wnt signaling pathway | 1.12e-03 | 32 | 32 | 2 | GO:2000050 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 1.75e-04 | 13 | 32 | 2 | GO:0030877 | |
| GeneOntologyCellularComponent | ciliary basal body | 2.15e-04 | 195 | 32 | 4 | GO:0036064 | |
| GeneOntologyCellularComponent | spindle | 6.93e-04 | 471 | 32 | 5 | GO:0005819 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 7.21e-04 | 26 | 32 | 2 | GO:0005847 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.03e-03 | 31 | 32 | 2 | GO:0005849 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.73e-03 | 1179 | 32 | 7 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.80e-03 | 1187 | 32 | 7 | GO:0099081 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 2.16e-03 | 899 | 32 | 6 | GO:0099513 | |
| MousePheno | abnormal circadian behavior period | 3.06e-05 | 36 | 24 | 3 | MP:0020468 | |
| Domain | SSXRD | 7.91e-05 | 8 | 32 | 2 | PF09514 | |
| Domain | SSXRD_motif | 7.91e-05 | 8 | 32 | 2 | IPR019041 | |
| Domain | CTLH | 1.02e-04 | 9 | 32 | 2 | SM00668 | |
| Domain | CTLH_C | 1.27e-04 | 10 | 32 | 2 | IPR006595 | |
| Domain | CTLH | 1.27e-04 | 10 | 32 | 2 | PS50897 | |
| Domain | KRAB_RELATED | 1.55e-04 | 11 | 32 | 2 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 2.19e-04 | 13 | 32 | 2 | IPR003655 | |
| Domain | LisH | 1.05e-03 | 28 | 32 | 2 | IPR006594 | |
| Domain | LisH | 1.05e-03 | 28 | 32 | 2 | SM00667 | |
| Domain | LISH | 1.05e-03 | 28 | 32 | 2 | PS50896 | |
| Domain | SET | 2.81e-03 | 46 | 32 | 2 | SM00317 | |
| Domain | Ser/Thr_kinase_AS | 3.09e-03 | 357 | 32 | 4 | IPR008271 | |
| Domain | KRAB | 3.12e-03 | 358 | 32 | 4 | PF01352 | |
| Domain | PROTEIN_KINASE_ST | 3.25e-03 | 362 | 32 | 4 | PS00108 | |
| Domain | SET_dom | 3.31e-03 | 50 | 32 | 2 | IPR001214 | |
| Domain | SET | 3.31e-03 | 50 | 32 | 2 | PS50280 | |
| Domain | KRAB | 3.48e-03 | 369 | 32 | 4 | SM00349 | |
| Domain | KRAB | 3.52e-03 | 370 | 32 | 4 | IPR001909 | |
| Domain | Protein_kinase_ATP_BS | 3.83e-03 | 379 | 32 | 4 | IPR017441 | |
| Domain | Pkinase | 3.90e-03 | 381 | 32 | 4 | PF00069 | |
| Domain | CH | 5.53e-03 | 65 | 32 | 2 | SM00033 | |
| Domain | zf-C2H2 | 6.08e-03 | 693 | 32 | 5 | PF00096 | |
| Domain | CH | 6.39e-03 | 70 | 32 | 2 | PF00307 | |
| Domain | - | 6.57e-03 | 71 | 32 | 2 | 1.10.418.10 | |
| Domain | CH | 6.93e-03 | 73 | 32 | 2 | PS50021 | |
| Domain | CH-domain | 7.30e-03 | 75 | 32 | 2 | IPR001715 | |
| Domain | PROTEIN_KINASE_ATP | 7.51e-03 | 459 | 32 | 4 | PS00107 | |
| Domain | Prot_kinase_dom | 9.34e-03 | 489 | 32 | 4 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 9.60e-03 | 493 | 32 | 4 | PS50011 | |
| Domain | ZINC_FINGER_C2H2_2 | 9.64e-03 | 775 | 32 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 9.74e-03 | 777 | 32 | 5 | PS00028 | |
| Domain | Rho_GTPase_activation_prot | 9.93e-03 | 88 | 32 | 2 | IPR008936 | |
| Domain | Znf_C2H2 | 1.12e-02 | 805 | 32 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.14e-02 | 808 | 32 | 5 | SM00355 | |
| Domain | Kinase-like_dom | 1.32e-02 | 542 | 32 | 4 | IPR011009 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.07e-06 | 43 | 26 | 4 | M39706 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 1.52e-06 | 110 | 26 | 5 | MM15977 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.67e-06 | 48 | 26 | 4 | M219 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 3.13e-06 | 56 | 26 | 4 | M1053 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 4.46e-06 | 18 | 26 | 3 | M31 | |
| Pathway | PID_FOXO_PATHWAY | 9.70e-05 | 49 | 26 | 3 | M136 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 1.09e-04 | 51 | 26 | 3 | M39721 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.57e-04 | 151 | 26 | 4 | M19428 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.69e-04 | 59 | 26 | 3 | M261 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 2.52e-04 | 13 | 26 | 2 | M18009 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 2.81e-04 | 70 | 26 | 3 | M938 | |
| Pathway | REACTOME_ACTIVATION_OF_SMO | 2.94e-04 | 14 | 26 | 2 | MM15228 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 4.37e-04 | 17 | 26 | 2 | M39525 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 4.91e-04 | 18 | 26 | 2 | MM14759 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 5.69e-04 | 89 | 26 | 3 | M39563 | |
| Pathway | WNT_SIGNALING | 5.69e-04 | 89 | 26 | 3 | M5493 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 7.54e-04 | 98 | 26 | 3 | M39731 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 8.98e-04 | 239 | 26 | 4 | MM14756 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 9.22e-04 | 105 | 26 | 3 | MM15206 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 1.14e-03 | 113 | 26 | 3 | M39669 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.25e-03 | 261 | 26 | 4 | M42565 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.47e-03 | 31 | 26 | 2 | MM15154 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 1.57e-03 | 32 | 26 | 2 | M23 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.98e-03 | 137 | 26 | 3 | MM15182 | |
| Pathway | WP_MELATONIN_METABOLISM_AND_EFFECTS | 2.09e-03 | 37 | 26 | 2 | M39418 | |
| Pathway | WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING | 2.09e-03 | 37 | 26 | 2 | M39817 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.20e-03 | 142 | 26 | 3 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.52e-03 | 149 | 26 | 3 | M41805 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 2.81e-03 | 326 | 26 | 4 | M39379 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.82e-03 | 155 | 26 | 3 | M41808 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 2.95e-03 | 44 | 26 | 2 | MM15878 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.97e-03 | 158 | 26 | 3 | MM14791 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 3.65e-03 | 49 | 26 | 2 | MM1442 | |
| Pubmed | Physiological role for casein kinase 1 in glutamatergic synaptic transmission. | 8.84e-12 | 6 | 32 | 4 | 16014721 | |
| Pubmed | 4.12e-11 | 8 | 32 | 4 | 17244647 | ||
| Pubmed | 4.12e-11 | 8 | 32 | 4 | 21930935 | ||
| Pubmed | Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin. | 4.12e-11 | 8 | 32 | 4 | 17101137 | |
| Pubmed | 1.23e-10 | 10 | 32 | 4 | 25500533 | ||
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 25665722 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 7797465 | ||
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 7.35e-09 | 161 | 32 | 6 | 36398662 | |
| Pubmed | Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways. | 1.41e-08 | 6 | 32 | 3 | 11884395 | |
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 21179498 | ||
| Pubmed | Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. | 2.47e-08 | 7 | 32 | 3 | 12000790 | |
| Pubmed | SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis. | 2.47e-08 | 7 | 32 | 3 | 30177679 | |
| Pubmed | 5.92e-08 | 9 | 32 | 3 | 20708156 | ||
| Pubmed | 1.16e-07 | 11 | 32 | 3 | 21709260 | ||
| Pubmed | Association of CPI-17 with protein kinase C and casein kinase I. | 3.19e-07 | 15 | 32 | 3 | 15003508 | |
| Pubmed | 7.23e-07 | 76 | 32 | 4 | 27542412 | ||
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 8.20e-07 | 2 | 32 | 2 | 9522121 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 23690993 | ||
| Pubmed | Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. | 8.20e-07 | 2 | 32 | 2 | 25994086 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 25404202 | ||
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 8.20e-07 | 2 | 32 | 2 | 37723657 | |
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 8.20e-07 | 2 | 32 | 2 | 36929849 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 35695793 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34216174 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 9632646 | ||
| Pubmed | Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling. | 8.20e-07 | 2 | 32 | 2 | 37108197 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19043076 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 22981886 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 23354688 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24424021 | ||
| Pubmed | Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. | 8.20e-07 | 2 | 32 | 2 | 36542875 | |
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 8.20e-07 | 2 | 32 | 2 | 38852281 | |
| Pubmed | 1.08e-06 | 22 | 32 | 3 | 22305495 | ||
| Pubmed | 1.43e-06 | 90 | 32 | 4 | 19515997 | ||
| Pubmed | Casein kinase 1-epsilon or 1-delta required for Wnt-mediated intestinal stem cell maintenance. | 2.46e-06 | 3 | 32 | 2 | 28963394 | |
| Pubmed | Targeting of the circadian clock via CK1δ/ε to improve glucose homeostasis in obesity. | 2.46e-06 | 3 | 32 | 2 | 27439882 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 31353086 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 19805514 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 8786104 | ||
| Pubmed | Casein kinase 1 proteomics reveal prohibitin 2 function in molecular clock. | 2.46e-06 | 3 | 32 | 2 | 22384121 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 25724478 | ||
| Pubmed | Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. | 2.46e-06 | 3 | 32 | 2 | 24616378 | |
| Pubmed | Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. | 2.46e-06 | 3 | 32 | 2 | 25242043 | |
| Pubmed | CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. | 2.46e-06 | 3 | 32 | 2 | 28878021 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 19805222 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 32321936 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 12270714 | ||
| Pubmed | Type I Interferons Control Proliferation and Function of the Intestinal Epithelium. | 2.46e-06 | 3 | 32 | 2 | 26811327 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 28655862 | ||
| Pubmed | CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch. | 4.92e-06 | 4 | 32 | 2 | 29784789 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 38147624 | ||
| Pubmed | Cx43 phosphorylation sites regulate pancreatic cancer metastasis. | 4.92e-06 | 4 | 32 | 2 | 33603164 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 37578019 | ||
| Pubmed | The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. | 4.92e-06 | 4 | 32 | 2 | 32728212 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 10441327 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 20421981 | ||
| Pubmed | Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth. | 4.92e-06 | 4 | 32 | 2 | 21422228 | |
| Pubmed | Regulation of p53-MDMX interaction by casein kinase 1 alpha. | 4.92e-06 | 4 | 32 | 2 | 16024788 | |
| Pubmed | Therapeutic Targeting of Casein Kinase 1δ/ε in an Alzheimer's Disease Mouse Model. | 4.92e-06 | 4 | 32 | 2 | 31334659 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 30487124 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 9349507 | ||
| Pubmed | FAM83D directs protein kinase CK1α to the mitotic spindle for proper spindle positioning. | 4.92e-06 | 4 | 32 | 2 | 31338967 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 8972483 | ||
| Pubmed | Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. | 4.92e-06 | 4 | 32 | 2 | 18231586 | |
| Pubmed | Involvement of casein kinase Iepsilon in cytokine-induced granulocytic differentiation. | 4.92e-06 | 4 | 32 | 2 | 15070676 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 20192920 | ||
| Pubmed | PML enhances the regulation of p53 by CK1 in response to DNA damage. | 4.92e-06 | 4 | 32 | 2 | 18246126 | |
| Pubmed | Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I epsilon. | 8.19e-06 | 5 | 32 | 2 | 10848614 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 30651631 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 11865049 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 29191835 | ||
| Pubmed | Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. | 8.19e-06 | 5 | 32 | 2 | 30064974 | |
| Pubmed | Casein kinase 1 delta regulates the pace of the mammalian circadian clock. | 8.19e-06 | 5 | 32 | 2 | 19414593 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 17027228 | ||
| Pubmed | The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer. | 8.19e-06 | 5 | 32 | 2 | 33754069 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 37944068 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 36989576 | ||
| Pubmed | Essential roles of CKIdelta and CKIepsilon in the mammalian circadian clock. | 8.19e-06 | 5 | 32 | 2 | 19948962 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 29463694 | ||
| Pubmed | Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer. | 8.19e-06 | 5 | 32 | 2 | 25628462 | |
| Pubmed | A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. | 8.19e-06 | 5 | 32 | 2 | 23890787 | |
| Pubmed | CKIα ablation highlights a critical role for p53 in invasiveness control. | 8.19e-06 | 5 | 32 | 2 | 21331045 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 15687492 | ||
| Pubmed | Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. | 1.23e-05 | 6 | 32 | 2 | 11955436 | |
| Pubmed | Casein kinase I epsilon associates with and phosphorylates the tight junction protein occludin. | 1.23e-05 | 6 | 32 | 2 | 16616143 | |
| Pubmed | A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). | 1.23e-05 | 6 | 32 | 2 | 20048001 | |
| Pubmed | Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway. | 1.23e-05 | 6 | 32 | 2 | 22609948 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 18708403 | ||
| Pubmed | Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2. | 1.23e-05 | 6 | 32 | 2 | 17962809 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 19118383 | ||
| Pubmed | Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. | 1.23e-05 | 6 | 32 | 2 | 11818547 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 25124033 | ||
| Pubmed | Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. | 1.23e-05 | 6 | 32 | 2 | 11583622 | |
| Pubmed | Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. | 1.23e-05 | 6 | 32 | 2 | 17318175 | |
| Pubmed | MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling. | 1.23e-05 | 6 | 32 | 2 | 32511789 | |
| Pubmed | MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism. | 1.23e-05 | 6 | 32 | 2 | 33667384 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 17686994 | ||
| Pubmed | Bifurcating action of Smoothened in Hedgehog signaling is mediated by Dlg5. | 1.72e-05 | 7 | 32 | 2 | 25644602 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 10668202 | ||
| Pubmed | Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. | 1.72e-05 | 7 | 32 | 2 | 10617630 | |
| Interaction | DBNDD1 interactions | 1.45e-08 | 4 | 32 | 3 | int:DBNDD1 | |
| Interaction | FKBPL interactions | 3.33e-07 | 37 | 32 | 4 | int:FKBPL | |
| Interaction | SNX22 interactions | 1.03e-06 | 13 | 32 | 3 | int:SNX22 | |
| Interaction | DVL2 interactions | 1.90e-06 | 557 | 32 | 8 | int:DVL2 | |
| Interaction | ANKRD49 interactions | 2.40e-06 | 60 | 32 | 4 | int:ANKRD49 | |
| Interaction | DCK interactions | 3.31e-06 | 65 | 32 | 4 | int:DCK | |
| Interaction | ARHGAP22 interactions | 3.97e-06 | 68 | 32 | 4 | int:ARHGAP22 | |
| Interaction | PPP1R14A interactions | 5.49e-06 | 22 | 32 | 3 | int:PPP1R14A | |
| Interaction | ATOH1 interactions | 7.61e-06 | 80 | 32 | 4 | int:ATOH1 | |
| Interaction | FAM83D interactions | 8.39e-06 | 82 | 32 | 4 | int:FAM83D | |
| Interaction | FAM110D interactions | 9.22e-06 | 26 | 32 | 3 | int:FAM110D | |
| Interaction | SNX24 interactions | 2.30e-05 | 35 | 32 | 3 | int:SNX24 | |
| Interaction | ZNF618 interactions | 2.51e-05 | 36 | 32 | 3 | int:ZNF618 | |
| Interaction | HMMR interactions | 2.59e-05 | 109 | 32 | 4 | int:HMMR | |
| Interaction | FAM83A interactions | 3.45e-05 | 40 | 32 | 3 | int:FAM83A | |
| Interaction | FAM83B interactions | 6.90e-05 | 140 | 32 | 4 | int:FAM83B | |
| Interaction | FAM83H interactions | 7.09e-05 | 141 | 32 | 4 | int:FAM83H | |
| Interaction | DRICH1 interactions | 1.09e-04 | 10 | 32 | 2 | int:DRICH1 | |
| Interaction | MTMR4 interactions | 1.10e-04 | 158 | 32 | 4 | int:MTMR4 | |
| Interaction | CACNG4 interactions | 1.11e-04 | 59 | 32 | 3 | int:CACNG4 | |
| Interaction | DBNDD2 interactions | 1.33e-04 | 11 | 32 | 2 | int:DBNDD2 | |
| Interaction | GAPVD1 interactions | 1.82e-04 | 180 | 32 | 4 | int:GAPVD1 | |
| Interaction | FAM110C interactions | 1.88e-04 | 13 | 32 | 2 | int:FAM110C | |
| Interaction | MIER1 interactions | 2.75e-04 | 80 | 32 | 3 | int:MIER1 | |
| Interaction | PPP4R1L interactions | 3.52e-04 | 87 | 32 | 3 | int:PPP4R1L | |
| Interaction | ZNF217 interactions | 3.89e-04 | 90 | 32 | 3 | int:ZNF217 | |
| Interaction | BACH2 interactions | 3.89e-04 | 90 | 32 | 3 | int:BACH2 | |
| Interaction | C6orf141 interactions | 4.15e-04 | 92 | 32 | 3 | int:C6orf141 | |
| Interaction | STOX2 interactions | 5.03e-04 | 21 | 32 | 2 | int:STOX2 | |
| Interaction | FAM170A interactions | 5.53e-04 | 22 | 32 | 2 | int:FAM170A | |
| Interaction | FAM110A interactions | 5.61e-04 | 102 | 32 | 3 | int:FAM110A | |
| Interaction | PER3 interactions | 6.60e-04 | 24 | 32 | 2 | int:PER3 | |
| Interaction | FAM199X interactions | 7.16e-04 | 25 | 32 | 2 | int:FAM199X | |
| Interaction | BACH1 interactions | 7.18e-04 | 111 | 32 | 3 | int:BACH1 | |
| Interaction | SMARCA4 interactions | 7.48e-04 | 462 | 32 | 5 | int:SMARCA4 | |
| Interaction | FAM83G interactions | 7.75e-04 | 26 | 32 | 2 | int:FAM83G | |
| Interaction | SSMEM1 interactions | 8.16e-04 | 116 | 32 | 3 | int:SSMEM1 | |
| Interaction | KLHL22 interactions | 1.01e-03 | 125 | 32 | 3 | int:KLHL22 | |
| Cytoband | 4p16.3 | 1.62e-03 | 85 | 32 | 2 | 4p16.3 | |
| Cytoband | 19q13.43 | 1.70e-03 | 87 | 32 | 2 | 19q13.43 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.73e-04 | 17 | 21 | 2 | 1197 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.17e-03 | 718 | 21 | 5 | 28 | |
| Coexpression | GSE27786_LIN_NEG_VS_MONO_MAC_DN | 4.19e-06 | 200 | 32 | 5 | M4798 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP | 3.02e-05 | 7 | 32 | 2 | MM567 | |
| Drug | di-t-butylphosphite | 6.71e-10 | 10 | 32 | 4 | CID000518693 | |
| Drug | 2-amino-5-(N-ethylcarboxyamido)-pentanoic acid | 6.71e-10 | 10 | 32 | 4 | CID000194789 | |
| Drug | CKI-8 | 6.71e-10 | 10 | 32 | 4 | CID000486026 | |
| Drug | Asptpsa | 6.71e-10 | 10 | 32 | 4 | CID000132853 | |
| Drug | 5-chloroisoquinoline | 2.28e-09 | 13 | 32 | 4 | CID000224933 | |
| Drug | AC1Q5W8U | 4.34e-09 | 15 | 32 | 4 | CID000006483 | |
| Drug | S-ethylcysteine | 6.42e-08 | 28 | 32 | 4 | CID000030993 | |
| Drug | NG97 | 8.58e-08 | 30 | 32 | 4 | CID006604931 | |
| Drug | diisopropylphosphate | 8.58e-08 | 30 | 32 | 4 | CID000074162 | |
| Drug | cKP | 8.58e-08 | 30 | 32 | 4 | CID005494415 | |
| Drug | IC 261 | 8.79e-08 | 7 | 32 | 3 | ctd:C411652 | |
| Drug | AC1L1GFH | 3.82e-07 | 43 | 32 | 4 | CID000003660 | |
| Drug | 6-hydroxymethyl-7,8-dihydropterin | 4.19e-07 | 44 | 32 | 4 | CID000000218 | |
| Drug | Pp55 | 7.07e-07 | 50 | 32 | 4 | CID000132900 | |
| Drug | CKI-7 | 8.96e-07 | 53 | 32 | 4 | CID000129236 | |
| Drug | anthraquinone | 1.48e-06 | 60 | 32 | 4 | CID000006780 | |
| Drug | methylglyoxal bis(guanylhydrazone | 1.58e-06 | 61 | 32 | 4 | CID000009991 | |
| Drug | mazindol | 3.84e-06 | 76 | 32 | 4 | CID000004020 | |
| Drug | CK2 inhibitor | 6.59e-06 | 87 | 32 | 4 | CID000001694 | |
| Drug | DAPH1 | 7.21e-06 | 27 | 32 | 3 | CID000133027 | |
| Drug | cnicin | 8.23e-06 | 92 | 32 | 4 | CID000091176 | |
| Drug | IC261 | 9.75e-06 | 96 | 32 | 4 | CID000003674 | |
| Drug | rutin | 1.06e-05 | 98 | 32 | 4 | CID005280805 | |
| Drug | australifungin | 1.91e-05 | 5 | 32 | 2 | CID005276375 | |
| Drug | Cys-cys | 2.28e-05 | 119 | 32 | 4 | CID000152238 | |
| Drug | Kemptide | 2.68e-05 | 124 | 32 | 4 | CID000100074 | |
| Drug | Attpsa | 2.86e-05 | 6 | 32 | 2 | CID005487511 | |
| Drug | NDSB195 | 2.86e-05 | 6 | 32 | 2 | CID000448830 | |
| Drug | NSC401575 | 3.13e-05 | 129 | 32 | 4 | CID000003165 | |
| Drug | 2,3-DPG | 3.96e-05 | 137 | 32 | 4 | CID000000061 | |
| Drug | emodin | 4.55e-05 | 142 | 32 | 4 | CID000003220 | |
| Drug | dl-Lysine | 4.92e-05 | 290 | 32 | 5 | CID000000866 | |
| Drug | 7,8-diOH-CPZ | 6.85e-05 | 9 | 32 | 2 | CID000159916 | |
| Drug | DAPH2 | 7.38e-05 | 58 | 32 | 3 | CID006711154 | |
| Drug | CK1 inhibitor | 1.04e-04 | 11 | 32 | 2 | CID006419753 | |
| Drug | BE-23372M | 1.04e-04 | 11 | 32 | 2 | CID005311105 | |
| Drug | NSC406942 | 1.19e-04 | 565 | 32 | 6 | CID000001115 | |
| Drug | K-Cl | 1.21e-04 | 567 | 32 | 6 | CID000004873 | |
| Drug | pppAp | 1.48e-04 | 13 | 32 | 2 | CID000189064 | |
| Drug | D0303 | 1.48e-04 | 13 | 32 | 2 | CID009809426 | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 6342_UP | |
| Drug | matairesinol | 1.72e-04 | 14 | 32 | 2 | CID000119205 | |
| Drug | Gvapspat amide | 1.99e-04 | 15 | 32 | 2 | CID000125015 | |
| Drug | sulfonamide analog 1 | 2.18e-04 | 213 | 32 | 4 | CID005327336 | |
| Drug | Phosphoryl | 2.26e-04 | 215 | 32 | 4 | CID006857426 | |
| Drug | DNTB | 2.30e-04 | 216 | 32 | 4 | CID000015325 | |
| Drug | 32 P | 2.36e-04 | 405 | 32 | 5 | CID000448772 | |
| Drug | 1q66 | 2.57e-04 | 17 | 32 | 2 | CID006323390 | |
| Drug | 1,4-bis-(phenoxyacetyl)piperazine | 2.69e-04 | 225 | 32 | 4 | CID001008511 | |
| Drug | LMWH | 2.83e-04 | 663 | 32 | 6 | CID000000772 | |
| Drug | Akti-1/2 | 3.22e-04 | 19 | 32 | 2 | CID010196499 | |
| Drug | A-443654 | 3.58e-04 | 20 | 32 | 2 | CID010172943 | |
| Drug | spermidine | 4.19e-04 | 253 | 32 | 4 | CID000001102 | |
| Drug | NHS-LC-biotin | 4.75e-04 | 23 | 32 | 2 | CID000083874 | |
| Drug | NSC-364372 | 5.33e-04 | 484 | 32 | 5 | CID000435143 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.63e-11 | 7 | 29 | 4 | DOID:0060807 (implicated_via_orthology) | |
| Disease | progression free survival, ovarian serous carcinoma | 2.13e-04 | 22 | 29 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | disease progression measurement | 1.65e-03 | 61 | 29 | 2 | EFO_0008336 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.02e-03 | 257 | 29 | 3 | DOID:10652 (is_marker_for) | |
| Disease | response to angiotensin-converting enzyme inhibitor | 2.67e-03 | 78 | 29 | 2 | EFO_0005325 | |
| Disease | urate measurement, bone density | 3.00e-03 | 619 | 29 | 4 | EFO_0003923, EFO_0004531 | |
| Disease | DNA methylation | 3.70e-03 | 656 | 29 | 4 | GO_0006306 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YNLSKHYRRFFQNII | 4721 | Q86UQ4 | |
| LERLYQRYFFRLNQS | 226 | O95622 | |
| FNFYNYLRTHPLLLR | 1811 | Q9Y485 | |
| LIQQFRYDNYRLHQL | 266 | Q7L5Y9 | |
| YRLFITFHLQNFRNG | 116 | Q8WX39 | |
| YSYLRQLFRNLFHRQ | 266 | P48730 | |
| FLQRDLFNGIIYYRH | 586 | Q5H8C1 | |
| FRILFRTLNHQYDYT | 281 | Q8N752 | |
| ARRQYLRRLHYFQKN | 806 | Q86VI3 | |
| VAFQYHRQIFYRTCR | 331 | Q9NQV7 | |
| RINHYQQRLQSLYFK | 766 | Q9Y4D1 | |
| ARAVRNNYRHYFLSS | 401 | Q6ZNC8 | |
| FARRFRLYLASHPQY | 41 | Q9NRF2 | |
| YQLQVNTLRRYKRHF | 151 | O75446 | |
| FRILFRTLNHQYDYT | 281 | P48729 | |
| YFNYKRRHNLDNLLQ | 666 | O75376 | |
| VAFQYHRQIFYRTCR | 331 | Q9NQW5 | |
| VLRYLFTFLNHLAQY | 631 | P98171 | |
| LPNHFSNRYYNRLVR | 151 | P52823 | |
| FRLLAQYFQYRQLNL | 91 | Q8IUQ0 | |
| FQEYYRQRLRYQQHL | 426 | O94967 | |
| LFTSPQRVYRNFHYR | 56 | Q53HI1 | |
| KLLHYLARNFYNLRF | 4401 | Q15413 | |
| QYQRLHFFLALYLAN | 201 | Q8NFV5 | |
| AFRQNASLIRHRRYY | 376 | Q6ECI4 | |
| VFTYVQSLYNHLRRF | 446 | Q2TAL5 | |
| EANFFIHRRLLYNRF | 41 | Q9BZD6 | |
| YHTVNRRYREFLNLQ | 576 | Q92543 | |
| SYARQELQRLYRIFH | 56 | Q8NAM6 | |
| QARFSQRRYLLQHQF | 206 | A8K8V0 | |
| YSYLRQLFRNLFHRQ | 266 | P49674 | |
| LFFQVRYHRYRLQLR | 286 | Q8N9F0 |